GlassScriptPhysician profile
Surya M Artham
NPI 1215127493
$5,077.33
in general payments reported to CMS, 2019-2025
27 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $163 · 2021: $18.54 · 2022: $610 · 2023: $760 · 2024: $718 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,495 · Travel and Lodging: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,494.59 |
| Travel and Lodging | $350.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,215.51 | 2019-2025 | Impella |
| Cvrx, INC. | $644.12 | 2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $644.07 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $341.72 | 2019-2022 | |
| Boston Scientific Corporation | $258.33 | 2024-2025 | Ekosonic, Watchman Flx |
| Amgen INC. | $241.19 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $236.89 | 2019-2025 | |
| Penumbra, INC. | $236.29 | 2019-2025 | Indigo System |
| Abbott Laboratories | $184.80 | 2019-2023 | Mitraclip |
| Pfizer INC. | $153.63 | 2019-2025 | |
| Shockwave Medical, INC | $123.50 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $112.09 | 2024 | Kengreal |
| Kestra Medical Technology Services, INC. | $100.43 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $79.55 | 2022-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $69.77 | 2023-2024 | Verquvo |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $67.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.41 | 2022-2023 | Jardiance |
| Atricure, INC. | $58.18 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $48.13 | 2020-2024 | Farxiga |
| Novo Nordisk INC | $47.43 | 2025 | Wegovy |
| Impulse Dynamics (USA) INC. | $34.85 | 2022 | |
| Amarin Pharma, INC. | $31.51 | 2019-2020 | |
| Surmodics, INC. | $20.38 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Kiniksa Pharmaceuticals International, Plc | $20.17 | 2024 | Arcalyst |
| Medtronic, INC. | $17.37 | 2023 | Onyx Frontier |
| Cook Medical LLC | $15.98 | 2019 | |
| Recor Medical INC | $14.72 | 2025 | Paradise Ultrasound Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surya Artham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.